Update: Intuitive Surgical Drops as 2026 Global da Vinci Growth Outlook Tweak, $450 Million Charge Chip Away at Q3 Adjusted Earnings, Revenue Beats

06:10 AM EDT, 10/21/2026 (MT Newswires) -- (Updates with the stock move, outlook, and the legal charge in the headline, first and last two paragraphs.) Intuitive Surgical's (ISRG) shares fell 7.8% in Wednesday's premarket after the company adjusted its global da Vinci procedure growth target range for 2026 and reported a $450 million settlement charge that outweighed its Q3 adjusted earnings and revenue beat. The company reported Q3 adjusted earnings late Tuesday of $3.00 per diluted share, up from $2.40 a year earlier. Analysts polled by FactSet expected $2.65. Revenue for the quarter ended Sept. 30 was $3.05 billion, up from $2.51 billion a year earlier. Analysts expected $2.91 billion. The company said it expects global da Vinci procedure growth to be closer to the midpoint of the 14% to 15% jump anticipated for 2026. On July 16, the company forecast this year's range of about 13.5% to 15.5%. The company also said it recorded a $450 million charge to selling, general, and administrative expenses in Q3. The settlement follows mediation in the "In re: da Vinci Surgical Robot Antitrust Litigation" class action and remains subject to preliminary and final court approval.